Hair loss, explained. Explore research and treatments.

Learn

What each drug, ingredient and condition is, with the top and newest studies on each. Open the index »

Research

Each month's hair loss papers, summarized, with every study linked to its source. Browse by month »

Community

Ask questions and compare regimens and results with others treating hair loss. Open the forum »

New in research

  1. Topical Minoxidil for Female Pattern Hair Loss: Clinical Outcomes in Postmenopausal Women

    A review with phase III post hoc data found once-daily 5% minoxidil foam regrew hair in postmenopausal women regardless of FPHL severity.
  2. Carnosic acid–loaded nanostructured lipid carriers for targeted follicular delivery and hair regeneration in androgenetic alopecia

    A carnosic acid nanocarrier gel regrew hair faster than 2% minoxidil and cut inflammatory markers more in a testosterone-induced alopecia model.
  3. Curcumin-Loaded Zinc-Ginsenoside MOF Microneedles Attenuate Androgen-Induced Follicular Damage and Promote Hair Regrowth

    Curcumin-loaded ginsenoside-zinc microneedles blocked DHT damage and accelerated hair regrowth via Wnt/β-catenin in a mouse AGA model.
  4. Treatment Timing and Early Hair Regrowth in Relation to Response to Intravenous Methylprednisolone Pulse Therapy in Alopecia Areata: A Retrospective Cohort Study

    In 72 alopecia areata patients, starting IV methylprednisolone within 6 months and 3-month regrowth predicted 6-month response.
  5. Cardiovascular Safety of Oral Minoxidil Use in Hair-Loss Patients: A Systematic Review and Meta-Analysis

    A meta-analysis of 63 studies found cardiovascular events with oral minoxidil uncommon and no consistent excess risk versus comparators, though risk exceeded topical minoxidil and women appeared more susceptible; individualized monitoring research is still needed.
  6. Forty-Eight-Week Real-World Outcomes of Ritlecitinib in Alopecia Areata: Delayed Responses and Predictive Value of Change in SALT Score at Week 24

    Real-world ritlecitinib gave SALT ≤20 in 39% of severe AA patients by week 48, with some responding only after week 24.
  7. Follicle-Targeted Deep Eutectic Solvent-Lipid Hybrid Nanocarriers for Phloretin against Androgenetic Alopecia

    A phloretin hybrid nanocarrier stimulated dermal papilla cells, cut inflammation, and regrew hair in AGA models via Wnt/β-catenin and mTOR.
  8. Alopecia areata-associated white hair growth can occur independent of follicular cycling

    White hair occurred in 16% of 5,155 AA patients, linked to age, autoimmunity and allergy; most regained pigment with treatment.
  9. Evaluating current and emerging pharmacological treatment options for men with androgenetic alopecia

    A review concludes current drugs work best early and mainly preserve hair; transplantation remains the only fix where follicles are lost.
  10. Personalized minoxidil therapy in androgenetic alopecia: from SULT1A1 biomarkers to precision clinical management

    A review explains how follicular SULT1A1 testing can predict topical minoxidil response and enable personalized treatment algorithms.
View more new articles in Research →